نتائج البحث 71-80 من 3444 لعملية البحث عن anti-TNF drugs
The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and TTI-622 and ...
... drugs are safe for people to take. We also want ... A Study to Evaluate Maximizing Anti ... The purpose of this study is to monitor T cell responses from patients ...
... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
Page 1.
... treatment, or cannot be surgically removed. Drugs such as sapanisertib may ... Anti-cancer activity will be assessed every 6 weeks during therapy and ...
Brain Tumor Stem Cell Research Alfredo Quinones-Hinojosa.
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Drugs used in chemotherapy, such as cisplatin and ... anti-HER2 therapies, such as trastuzumab ... Drugs used in chemotherapy, such as temozolomide ...
The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.